AMERIPRISE FINANCIAL INC – Vertex Pharmaceuticals Incorporated Transaction History
AMERIPRISE FINANCIAL INC portfolio value:
$1.17B
portfolio value
AMERIPRISE FINANCIAL INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -11.42% | -520.95K shares | -114.94M | $289.54 | 4.04M |
| Q2 2022 | share | Decrease | -7.77% | -384.41K shares | -4.63M | $281.79 | 4.56M |
| Q1 2022 | share | Increase | +11.85% | 524.16K shares | 320.96M | $260.97 | 4.94M |
| Q4 2021 | share | Increase | +30.51% | 1.03M shares | 354.46M | $222.45 | 4.42M |
| Q3 2021 | share | Increase | +23.74% | 650.31K shares | 62.50M | $181.39 | 3.38M |
| Q2 2021 | share | Increase | +42.79% | 820.70K shares | 140.03M | $201.63 | 2.73M |
| Q1 2021 | share | Increase | +134.60% | 1.10M shares | 218.97M | $214.89 | 1.91M |
| Q4 2020 | share | Decrease | -2.65% | -22.26K shares | -35.22M | $236.34 | 817.6K |
| Q3 2020 | share | Decrease | -34.59% | -444.22K shares | -144.36M | $272.12 | 839.86K |
| Q2 2020 | share | Decrease | -40.90% | -888.79K shares | -144.26M | $290.31 | 1.28M |
| Q1 2020 | share | Decrease | -9.80% | -236.17K shares | -10.25M | $237.95 | 2.17M |
| Q4 2019 | share | Increase | +1.27% | 30.29K shares | 124.31M | $218.95 | 2.40M |
| Q3 2019 | share | Decrease | -2.58% | -62.95K shares | -44.77M | $169.42 | 2.37M |
| Q2 2019 | share | Increase | +3.31% | 78.25K shares | 13.13M | $183.38 | 2.44M |
| Q1 2019 | share | Decrease | -45.67% | -1.98M shares | -286.04M | $183.95 | 2.36M |
| Q4 2018 | share | Decrease | -24.26% | -1.39M shares | -384.81M | $165.71 | 4.35M |
| Q3 2018 | share | Decrease | -1.41% | -82.08K shares | 117.84M | $192.74 | 5.74M |
| Q2 2018 | share | Increase | +3.93% | 220.44K shares | 74.13M | $169.96 | 5.82M |
| Q1 2018 | share | Increase | +6.65% | 349.63K shares | 126.60M | $162.98 | 5.60M |
| Q4 2017 | share | Decrease | -3.25% | -176.7K shares | -38.98M | $149.86 | 5.25M |
| Q3 2017 | share | Decrease | -15.20% | -973.67K shares | 360K | $152.04 | 5.43M |
| Q2 2017 | share | Decrease | -22.24% | -1.83M shares | -75.57M | $128.87 | 6.40M |
| Q1 2017 | share | Decrease | -5.38% | -468.43K shares | 259.60M | $109.35 | 8.23M |
| Q4 2016 | share | Increase | +0.13% | 11.20K shares | -116.85M | $73.67 | 8.70M |
| Q3 2016 | share | Decrease | -3.64% | -328.64K shares | -17.88M | $87.21 | 8.69M |
| Q2 2016 | share | Decrease | -4.03% | -379.07K shares | 28.74M | $86.02 | 9.02M |
| Q1 2016 | share | Decrease | -1.95% | -187.04K shares | -459.28M | $79.49 | 9.40M |